US Patent Issued to DANA-FARBER CANCER INSTITUTE on Sept. 30 for "Acetylation writer inhibitor development and uses thereof" (Massachusetts, Tennessee Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,412, issued on Sept. 30, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).

"Acetylation writer inhibitor development and uses thereof" was invented by Jun Qi (Sharon, Mass.) and Adam D. Durbin (Memphis, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are bifunctional compounds (degraders) that target HAT EP300 for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the compounds to treat disease."

The patent was filed on Nov. 1, 2019, under Application No. 17/289,662.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/ne...